646 related articles for article (PubMed ID: 15207239)
1. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.
Alarcón JM; Malleret G; Touzani K; Vronskaya S; Ishii S; Kandel ER; Barco A
Neuron; 2004 Jun; 42(6):947-59. PubMed ID: 15207239
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.
Wood MA; Kaplan MP; Park A; Blanchard EJ; Oliveira AM; Lombardi TL; Abel T
Learn Mem; 2005; 12(2):111-9. PubMed ID: 15805310
[TBL] [Abstract][Full Text] [Related]
3. A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4.
Bourtchouladze R; Lidge R; Catapano R; Stanley J; Gossweiler S; Romashko D; Scott R; Tully T
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10518-22. PubMed ID: 12930888
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
Zheng F; Kasper LH; Bedford DC; Lerach S; Teubner BJ; Brindle PK
PLoS One; 2016; 11(1):e0146366. PubMed ID: 26730956
[TBL] [Abstract][Full Text] [Related]
5. Simulations suggest pharmacological methods for rescuing long-term potentiation.
Smolen P; Baxter DA; Byrne JH
J Theor Biol; 2014 Nov; 360():243-250. PubMed ID: 25034337
[TBL] [Abstract][Full Text] [Related]
6. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
Valor LM; Pulopulos MM; Jimenez-Minchan M; Olivares R; Lutz B; Barco A
J Neurosci; 2011 Feb; 31(5):1652-63. PubMed ID: 21289174
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner.
Bridi MS; Hawk JD; Chatterjee S; Safe S; Abel T
Neuropsychopharmacology; 2017 May; 42(6):1243-1253. PubMed ID: 27834392
[TBL] [Abstract][Full Text] [Related]
8. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.
Oike Y; Hata A; Mamiya T; Kaname T; Noda Y; Suzuki M; Yasue H; Nabeshima T; Araki K; Yamamura K
Hum Mol Genet; 1999 Mar; 8(3):387-96. PubMed ID: 9949198
[TBL] [Abstract][Full Text] [Related]
9. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
Korzus E
Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
[TBL] [Abstract][Full Text] [Related]
10. Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.
Viosca J; Lopez-Atalaya JP; Olivares R; Eckner R; Barco A
Neurobiol Dis; 2010 Jan; 37(1):186-94. PubMed ID: 19822209
[TBL] [Abstract][Full Text] [Related]
11. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
[TBL] [Abstract][Full Text] [Related]
12. To learn better, keep the HAT on.
Martin KC; Sun YE
Neuron; 2004 Jun; 42(6):879-81. PubMed ID: 15207231
[TBL] [Abstract][Full Text] [Related]
13. CBP histone acetyltransferase activity is a critical component of memory consolidation.
Korzus E; Rosenfeld MG; Mayford M
Neuron; 2004 Jun; 42(6):961-72. PubMed ID: 15207240
[TBL] [Abstract][Full Text] [Related]
14. CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain.
Wang J; Weaver IC; Gauthier-Fisher A; Wang H; He L; Yeomans J; Wondisford F; Kaplan DR; Miller FD
Dev Cell; 2010 Jan; 18(1):114-25. PubMed ID: 20152182
[TBL] [Abstract][Full Text] [Related]
15. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
[TBL] [Abstract][Full Text] [Related]
16. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
[TBL] [Abstract][Full Text] [Related]
17. The Kinase Function of MSK1 Regulates BDNF Signaling to CREB and Basal Synaptic Transmission, But Is Not Required for Hippocampal Long-Term Potentiation or Spatial Memory.
Daumas S; Hunter CJ; Mistry RB; Morè L; Privitera L; Cooper DD; Reyskens KM; Flynn HT; Morris RG; Arthur JS; Frenguelli BG
eNeuro; 2017; 4(1):. PubMed ID: 28275711
[TBL] [Abstract][Full Text] [Related]
18. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.
Petrij F; Giles RH; Dauwerse HG; Saris JJ; Hennekam RC; Masuno M; Tommerup N; van Ommen GJ; Goodman RH; Peters DJ
Nature; 1995 Jul; 376(6538):348-51. PubMed ID: 7630403
[TBL] [Abstract][Full Text] [Related]
19. The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism.
Bozdagi O; Rich E; Tronel S; Sadahiro M; Patterson K; Shapiro ML; Alberini CM; Huntley GW; Salton SR
J Neurosci; 2008 Sep; 28(39):9857-69. PubMed ID: 18815270
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.
Coupry I; Monnet L; Attia AA; Taine L; Lacombe D; Arveiler B
Hum Mutat; 2004 Mar; 23(3):278-84. PubMed ID: 14974086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
